Gujarat Biotech University Leads India's Effort for Affordable Cancer Therapy
Updated:1 year ago
Updated:1 year ago
Gandhinagar (Gujarat), June 25 (ANI): Gujarat Biotechnology University (GBU), in collaboration with Celliimune Biotech, is spearheading a transformative initiative to develop a cost-effective, indigenous version of CAR-T cell therapy—an advanced cancer treatment currently priced at ₹3–4 crore per dose abroad. With support from the Gujarat government, GBU will focus on cutting-edge research, while Celliimune leads production and clinical trials. CAR-T therapy involves genetically modifying a patient’s T-cells to identify and destroy cancer cells, especially in leukemia and lymphoma cases, showing remarkable success even in terminal patients. This effort aims to make life-saving treatment accessible and affordable, placing India on the global map of cancer innovation
Updated:2 years, 5 months ago
Amid dry winter in Kashmir, snow-clad Bangus Valley in Kupwara district emerges as winter wonderland
Updated:2 years, 5 months ago
Grand welcome given to sculptor Arun Yogiraj at Bengaluru Airport
Updated:2 years, 5 months ago
Injured WB CM Mamata Banerjee meets West Bengal Governor CV Anand Bose
Updated:2 years, 5 months ago
Couple set goals! Husband to lead Sikh Regiment, wife to command ICG contingent in R-Day Parade
Updated:2 years, 6 months ago
Inside India’s and Air India’s first Airbus A350 with luxurious seats, new interiors
Updated:2 years, 6 months ago
J-K: Srinagar’s Ghanta Ghar comes alive with spectacular Tricolour lighting